Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Andrew C. Akin"'
Autor:
Kevin T. Bennett, Sharon E. Bone, Andrew C. Akin, Eva R. Birnbaum, Anastasia V. Blake, Mark Brugh, Scott R. Daly, Jonathan W. Engle, Michael E. Fassbender, Maryline G. Ferrier, Stosh A. Kozimor, Laura M. Lilley, Christopher A. Martinez, Veronika Mocko, Francois M. Nortier, Benjamin W. Stein, Sara L. Thiemann, Christiaan Vermeulen
Publikováno v:
ACS Central Science, Vol 5, Iss 3, Pp 494-505 (2019)
Externí odkaz:
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
Autor:
D. Scott Wilbur, Andrew C. Akin, Eva R. Birnbaum, Mark Brugh, Michael E. Fassbender, Kevin D. John, Tara Mastren, Francois M. Nortier, Roy Copping
Publikováno v:
Nuclear Medicine and Biology. :69-73
Purpose Thorium-226 (half-life 30.6 m) is a radionuclide of interest for use in targeted alpha therapy applications. Due to its short half-life, 226Th must be provided through a radionuclide generator system from its parent 230U (20.8 d). Furthermore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fcf2666956fe80f96a5cce9c10c42cb
https://doi.org/10.1016/j.nucmedbio.2020.09.006
https://doi.org/10.1016/j.nucmedbio.2020.09.006
Autor:
Eva R. Birnbaum, Yawen Li, Andrew C. Akin, David H. Woen, Kevin T. Bennett, Donald K. Hamlin, Veronika Mocko, Eric Dorman, D. Scott Wilbur, Stosh A. Kozimor, Nickolas H. Anderson, Frankie D. White, Elodie Dalodière, Cecilia Eiroa-Lledo, Mark Brugh, Laura M. Lilley, Sara L. Thiemann, Maryline G. Ferrier, Anastasia V. Blake
Publikováno v:
Inorganic Chemistry. 59:6137-6146
Increasing access to the short-lived α-emitting radionuclide astatine-211 (211At) has the potential to advance targeted α-therapeutic treatment of disease and to solve challenges facing the medical...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2b939224c862d0a0617acefb13c260b
https://doi.org/10.1021/acs.inorgchem.0c00221
https://doi.org/10.1021/acs.inorgchem.0c00221
Autor:
Scott R. Daly, Kevin T. Bennett, Francois M. Nortier, Sharon E. Bone, Laura M. Lilley, C. Vermeulen, Veronika Mocko, Anastasia V. Blake, Benjamin W. Stein, Eva R. Birnbaum, Sara L. Thiemann, Christopher A. Martinez, Michael E. Fassbender, Maryline G. Ferrier, Jonathan W. Engle, Mark Brugh, Andrew C. Akin, Stosh A. Kozimor
Publikováno v:
ACS Central Science, Vol 5, Iss 3, Pp 494-505 (2019)
ACS Central Science
ACS Central Science
Radionuclides find widespread use in medical technologies for treating and diagnosing disease. Among successful and emerging radiotherapeutics, 119Sb has unique potential in targeted therapeutic applications for low-energy electron-emitting isotopes.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c00e2ccdf37d4a30837ed06ab77216d
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
https://doaj.org/article/116aeabb09ca4141a5f9a9981eb10e94
Autor:
Tyler A, Bailey, Veronika, Mocko, Katherine M, Shield, Dahlia D, An, Andrew C, Akin, Eva R, Birnbaum, Mark, Brugh, Jason C, Cooley, Jonathan W, Engle, Michael E, Fassbender, Stacey S, Gauny, Andrew L, Lakes, Francois M, Nortier, Ellen M, O'Brien, Sara L, Thiemann, Frankie D, White, Christiaan, Vermeulen, Stosh A, Kozimor, Rebecca J, Abergel
Publikováno v:
Nature chemistry. 13(3)
Developing targeted α-therapies has the potential to transform how diseases are treated. In these interventions, targeting vectors are labelled with α-emitting radioisotopes that deliver destructive radiation discretely to diseased cells while simu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::07526f0e14b7efa3c85d5ad6bf3a7dba
https://pubmed.ncbi.nlm.nih.gov/33318671
https://pubmed.ncbi.nlm.nih.gov/33318671